MyHorryNews

Vanda Pharmaceuticals Announces FDA Approval of BYSANTI™ (milsaperidone) for the treatment of Bipolar I Disorder and Schizophrenia - A New Chemical Entity Opening New ...

Vanda Pharmaceuticals Inc. (Nasdaq: VNDA) today announced that the U.S. Food and Drug Administration (FDA) has approved BYSANTI™ (milsaperidone) tablets, a first line therapy ...

Vanda Pharmaceuticals Inc.: Vanda Pharmaceuticals Announces FDA Approval of BYSANTI (milsaperidone) for the treatment of Bipolar I Disorder and Schizophrenia - A New Chemical ...

Vanda Pharmaceuticals Inc. (Nasdaq: VNDA) today announced that the U.S. Food and Drug Administration (FDA) has approved BYSANTI ...

Cindy Eckert, Women's Health Innovator, Named to TIME's 2026 TIME100 Health List of the World's Most Influential Leaders in Health

"I am deeply honored to be named to the TIME100 Health list," said Cindy Eckert, Founder and CEO of Sprout Pharmaceuticals. "Every disruptor dreams of the moment that culture reflects that what ...